A23V 2250/213
Lycopene
A23V2250/213 (Lycopene) appears on 4 US grants and 6 published applications in this corpus.
Search patents in A23V- Granted patents
- 4
- Published applications
- 6
- Assignees
- 4
- Inventors
- 9
- Latest grant
- 8 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 3 |
| 2022 | 2 | 0 |
| 2023 | 1 | 0 |
By publication year.
Recent patents
- Methods for improving the microbiome and its systemic effect8 Aug 2023US 11,717,492 B2IP Science Limited
- Use of carotenoid derivatives to reduce the toxicity and increase the efficacy of anti-EGFR antitumor treatments3 May 2022US 11,318,108 B2Associazione Oncologica Milanese Amo La Vita Onlus
- Antioxidant-enriched multivitamin composition and methods of use25 Jan 2022US 11,229,230 B2Callion Pharma, LLC
- Cocoa-based food products1 Dec 2020US 10,849,336 B2IP Science Limited
- Use of carotenoid derivatives to reduce the toxicity and increase the efficacy of anti-egfr antitumor treatments6 May 2021US 2021/0128491 A1Associazione Oncologica Milanese Amo La Vita Onlus
- Methods for improving the microbiome and its systemic effect18 Mar 2021US 2021/0077418 A1IP Science Limited
- Cocoa-based food products18 Feb 2021US 2021/0045405 A1IP Science Limited
- Antioxidant-enriched multivitamin composition and methods of use19 Sep 2019US 2019/0281876 A1Callion Pharma, LLC
- Methods for preparing active extract and application thereof20 Jun 2019US 2019/0183952 A1Beijing Boxin Nature Biotech Ltd.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.